Growing community of inventors

Gibsonia, PA, United States of America

Kevin Gibson

Average Co-Inventor Count = 4.24

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Kevin GibsonNaftali Kaminski (3 patents)Kevin GibsonJose David Herazo-Maya (3 patents)Kevin GibsonImre Noth (3 patents)Kevin GibsonJoe G N Garcia (2 patents)Kevin GibsonYong Huang (2 patents)Kevin GibsonSteven J Sibener (1 patent)Kevin GibsonThomas J Richards (1 patent)Kevin GibsonIvan Rosas (1 patent)Kevin GibsonKazuhisa Konishi (1 patent)Kevin GibsonMoises Selman (1 patent)Kevin GibsonBernadette R Gochuico (1 patent)Kevin GibsonKevin Gibson (4 patents)Naftali KaminskiNaftali Kaminski (9 patents)Jose David Herazo-MayaJose David Herazo-Maya (4 patents)Imre NothImre Noth (4 patents)Joe G N GarciaJoe G N Garcia (16 patents)Yong HuangYong Huang (4 patents)Steven J SibenerSteven J Sibener (4 patents)Thomas J RichardsThomas J Richards (1 patent)Ivan RosasIvan Rosas (1 patent)Kazuhisa KonishiKazuhisa Konishi (1 patent)Moises SelmanMoises Selman (1 patent)Bernadette R GochuicoBernadette R Gochuico (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The University of Chicago (4 from 917 patents)

2. University of Pittsburgh (3 from 1,863 patents)

3. University of Illinois (2 from 2,343 patents)

4. Instituto Nacional De Enfermedades Respiratorias Ismael Cosio Villegas—d.f. (1 from 1 patent)


4 patents:

1. 12109535 - Enrichment and separation of isotopes, isotopologues, or other chemical species, via differential embedding in a capture matrix

2. 10961582 - Biomarkers for assessing idiopathic pulmonary fibrosis

3. 10036069 - Biomarkers for assessing idiopathic pulmonary fibrosis

4. 8846341 - Marker panels for idiopathic pulmonary fibrosis diagnosis and evaluation

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/29/2025
Loading…